← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2004Last known activity
Jan 31, 2028
Timeline
1910s
- Jan 1, 1911
Indian Council of Medical Research— Founded
Drugs by trial phase (76 distinct, 47 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 3 (38 own, 0 via acquisition)
Phase 2 (14 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Birth Weight
- Brain Diseases
- Breast Neoplasms
- Candidiasis
- Candidiasis, Vulvovaginal
- Carcinoma
- Carcinoma, Hepatocellular
- Cholera
- Communicable Diseases
- Coronavirus Infections
- Death
- Diabetes Mellitus
- Diarrhea
- Dysentery
- Dyspepsia
- Encephalitis
- Encephalitis, Japanese
- Fibrosis
- Gastroenteritis
- Hepatic Encephalopathy
- HIV Infections
- Hypersensitivity
- Infections
- Insulin Resistance
- Irritable Bowel Syndrome
- Liver Diseases
- Meningitis
- Parasitic Diseases
- Pneumonia
- Pulmonary Fibrosis
- Respiratory Tract Infections
- Severe Acute Respiratory Syndrome
- Spinal Cord Injuries
- Syndrome
- Tuberculosis
- Tuberculosis, Pulmonary
- Vibrio Infections
- Virus Diseases
- Vitamin D Deficiency
- Wounds and Injuries
Recent trials (50)
- NCT07075315CollaboratorPhase 3Jan 31, 2028
- NCT07131306CollaboratorPhase 2Jan 31, 2027
- NCT07131540CollaboratorPhase 1Jan 31, 2026
- NCT07243704CollaboratorPhase 3Jan 1, 2026
- NCT07072624CollaboratorPhase 4Jul 23, 2025
- NCT06895252CollaboratorN/AMar 15, 2025
- NCT06890650CollaboratorN/AMar 15, 2025
- NCT06538077CollaboratorN/AAug 31, 2024
- NCT06431919CollaboratorN/AAug 31, 2024
- NCT05917340Lead sponsorPhase 3Mar 31, 2024
- NCT05836831CollaboratorPhase 4Aug 30, 2022
- NCT06055582CollaboratorN/AFeb 11, 2022
- NCT04936126CollaboratorPhase 4Aug 7, 2021
- NCT04713631Overall official - principal investigatorPhase 2Jan 31, 2021
- NCT04641481CollaboratorPhase 3Nov 25, 2020
Details
- Founded
- New Delhi, IN Jan 1, 1911
- Last known activity
- Jan 31, 2028